Figure 3From: Scope of nanotechnology in ovarian cancer therapeuticsA schematic representation of the strategy to target cancer cells using nanoparticles and immunoconjugated nanoparticles. Passive targeting occurs through drug loaded nanoparticles and active targeting is achieved with antibody conjugated nanoparticles.Back to article page